A Study to Evaluate if AC-084 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects
Clinical trial NCT02905253 · TERMINATED
Trial details
- NCT number
- NCT02905253
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-12
- Primary completion
- 2017-12-10
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.